- Previous Close
6,400.00 - Open
6,420.00 - Bid 6,350.00 x --
- Ask 6,400.00 x --
- Day's Range
6,340.00 - 6,420.00 - 52 Week Range
5,620.00 - 9,060.00 - Volume
3,240 - Avg. Volume
16,066 - Market Cap (intraday)
100.713B - Beta (5Y Monthly) 0.87
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield 100.00 (1.56%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
9,250.00
Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides radiography imaging software products, including Xmaru Pro, Xmaru View V1, Xmaru W, Xmaru RF, Xmaru NDT, Vetview Pro, VXV console, Ez Dent Vet, Xmaru PACS, and VXV PACS; medical information systems for veterinary hospitals; and engages in veterinary medical device and drug wholesale and retail business, as well as research and development of process facilities and deposition materials. The company was founded in 2011 and is headquartered in Hwaseong-si, South Korea.
www.rayence.comRecent News: 228850.KQ
View MorePerformance Overview: 228850.KQ
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 228850.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 228850.KQ
View MoreValuation Measures
Market Cap
100.71B
Enterprise Value
-44.75B
Trailing P/E
12.85
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.80
Price/Book (mrq)
0.41
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
6.24%
Return on Assets (ttm)
1.52%
Return on Equity (ttm)
3.19%
Revenue (ttm)
125.56B
Net Income Avi to Common (ttm)
7.83B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
150.21B
Total Debt/Equity (mrq)
1.94%
Levered Free Cash Flow (ttm)
-2.36B